Plexus Corp. (NASDAQ:PLXS – Get Free Report) CFO Patrick John Jermain sold 3,587 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $204.09, for a total transaction of $732,070.83. Following the completion of the transaction, the chief financial officer directly owned 16,882 shares in the company, valued at $3,445,447.38. This represents a 17.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Patrick John Jermain also recently made the following trade(s):
- On Tuesday, February 3rd, Patrick John Jermain sold 4,841 shares of Plexus stock. The shares were sold at an average price of $204.01, for a total value of $987,612.41.
- On Tuesday, November 11th, Patrick John Jermain sold 2,000 shares of Plexus stock. The stock was sold at an average price of $143.53, for a total value of $287,060.00.
Plexus Price Performance
NASDAQ PLXS traded up $5.15 during mid-day trading on Friday, hitting $206.22. The stock had a trading volume of 503,420 shares, compared to its average volume of 362,753. The firm’s 50 day moving average is $164.72 and its 200 day moving average is $147.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.75. The stock has a market capitalization of $5.52 billion, a price-to-earnings ratio of 32.07 and a beta of 0.81. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $208.92.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on PLXS shares. Stifel Nicolaus lifted their target price on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research report on Friday, January 30th. Wall Street Zen lowered shares of Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Needham & Company LLC upped their target price on shares of Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a report on Friday, October 24th. Finally, Benchmark raised their price target on shares of Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Plexus currently has a consensus rating of “Hold” and an average target price of $189.20.
Read Our Latest Analysis on PLXS
Institutional Trading of Plexus
Hedge funds have recently added to or reduced their stakes in the company. American Century Companies Inc. grew its holdings in Plexus by 44.2% during the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after acquiring an additional 338,119 shares in the last quarter. Balyasny Asset Management L.P. acquired a new stake in shares of Plexus in the 3rd quarter valued at $12,509,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Plexus by 965.0% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock worth $11,704,000 after purchasing an additional 73,295 shares during the last quarter. Qube Research & Technologies Ltd grew its stake in shares of Plexus by 37.1% during the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock worth $32,843,000 after purchasing an additional 65,644 shares in the last quarter. Finally, Bank of America Corp DE increased its holdings in Plexus by 53.6% in the second quarter. Bank of America Corp DE now owns 177,237 shares of the technology company’s stock valued at $23,982,000 after buying an additional 61,817 shares during the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Plexus
- What a Former CIA Agent Knows About the Coming Collapse
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trade this between 9:30 and 10:45 am EST
- Buy this stock tomorrow?
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
